Recent advances in the treatment of Pseudomonas aeruginosa infections in cystic fibrosis

Medicin og biovidenskab

• Pseudomonas Infections 100%
• Cystic Fibrosis 78%
• Respiratory Therapy 43%
• Lung 34%
• Biofilms 31%
• Aztreonam 21%
• Anti-Bacterial Agents 21%
• Tobramycin 20%
• Azithromycin 19%
• Antibiotic Prophylaxis 18%
• Quinolones 18%
• Pseudomonas 17%
• Patient Reported Outcome Measures 17%
• Ciprofloxacin 16%
• Sputum 15%
• Lysine 15%
• Inhalation 14%
• Pseudomonas aeruginosa 14%
• Therapeutics 13%
• Pneumonia 12%
• Clinical Trials 10%
• Pharmaceutical Preparations 6%